United Capital Financial Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Buy
11,586
+1,487
+15% +$33.4K ﹤0.01% 1423
2026
Q1
$228K Buy
10,099
+1,082
+12% +$24.9K ﹤0.01% 1498
2025
Q4
$215K Buy
9,017
+553
+7% +$13.8K ﹤0.01% 1301
2025
Q3
$223K Buy
8,464
+156
+2% +$4.01K ﹤0.01% 1120
2025
Q2
$237K Buy
+8,308
New +$223K ﹤0.01% 993
2019
Q3
– Sell
-10,790
Closed -$424K – 1378
2019
Q2
$424K Buy
+10,790
New +$427K ﹤0.01% 1098
2018
Q4
– Sell
-5,009
Closed -$258K – 1318
2018
Q3
$258K Buy
5,009
+233
+5% +$11.7K ﹤0.01% 1164
2018
Q2
$240K Sell
4,776
-112
-2% -$5.68K ﹤0.01% 1172
2018
Q1
$250K Buy
4,888
+76
+2% +$4.05K ﹤0.01% 1156
2017
Q4
$253K Buy
+4,812
New +$239K ﹤0.01% 1170

Other funds holding FMS

United Capital Financial Advisors's FMS Position: Q2 2026 in Review

United Capital Financial Advisors increased its Fresenius Medical Care (FMS) stake by 15% in Q2 2026, buying an estimated $33.4K and bringing the position to 11,586 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

United Capital Financial Advisors first reported a position in FMS in Q4 2017 and has held it in 10 quarters since. The position peaked at $424K in Q2 2019. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • United Capital Financial Advisors held 11,586 shares of Fresenius Medical Care worth $262K as of Q2 2026.
  • United Capital Financial Advisors bought 1,487 Fresenius Medical Care shares in Q2 2026, an estimated $33.4K.
  • Fresenius Medical Care made up ﹤0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #1423 holding.
  • United Capital Financial Advisors first reported a position in Fresenius Medical Care in Q4 2017 and has held it in 10 quarters since.
  • United Capital Financial Advisors's Fresenius Medical Care position peaked at $424K in Q2 2019.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.